Navigation Links
The Trout Group and The Conference Forum Announce Immuno-Oncology 360° Partnership to Fight a Wider Range of Cancers
Date:8/15/2017

The Conference Forum and The Trout Group will collaborate for the first time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates with the 4th Annual IO360° summit, to be held February 7-9, 2018, at The Roosevelt Hotel in New York City.

“With our experience in producing the Immuno-Oncology 360° NYC event and The Trout Group’s expertise in investor relations, this is an exciting opportunity for us to work together on building IO programming specifically for the investor community,” said Kate Woda, Director, Immuno-Oncology 360°.

On day three of the IO360° summit, The Trout Group Situation Room will feature fireside chats with IO biotech CEOs and executives, a panel discussion on “The Investor Lifecycle - How to Maneuver at Each Stage of Financing from Seed to Public Market,” and an IO CEO panel on “Checking the Target.”

Day one and day two of IO360° have sessions covering business aspects and investor relations for the immuno-oncology community. Dr Andrew Baum, Head of Global Healthcare; Managing Director, Equity Research, Citi, will deliver a keynote evaluating and forecasting the IO space. Additionally, Dr Bruce Booth of Atlas Venture will discuss the venture capitalist perspective, and GSK’s Dr Axel Hoos will moderate an investor roundtable.

Designed by lead advisors Dr Axel Hoos and Dr James Gulley, National Cancer Institute, the IO360° summit provides the most up-to-date research, data and progress to help IO stakeholders.

Expanding on the IO360° summit’s programming, a series of IO360° TroutTalks have been created as part of the ongoing TroutTalks Key Opinion Leaders (KOL) Series, which features conversations with prominent and up-and-coming researchers who are driving scientific innovation. The first of these IO360° panels is on August 17, 2017 at The Trout Group’s annual Hamptons CEO Roundtable. Another panel will be held in January 2018 at J.P. Morgan's Healthcare Conference in San Francisco. Panelists will be KOLs and IO industry experts addressing the most pressing topics and new research in the field.

The IO360° panelists at the Hamptons CEO Roundtable include:

  • Dr Axel Hoos, SVP, Oncology R&D, GlaxoSmithKline
  • Dr Charles G. Drake, Director, Genitourinary Oncology, and Associate Director, Clinical Research, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center
  • Dr Adi Hoess, CEO, Affimed
  • Dr Garry Menzel, CEO, TCR²
  • Øystein Soug, CEO, Targovax

Learn more about the Immuno-Oncology 360° summit.

About the Trout Group:
The Trout Group is a global investor relations and strategic advisory firm. Since 1996, Trout has been a leading strategic partner to the life sciences industry, connecting companies, the capital markets and innovations in the sector. Trout's unique suite of services at the intersection of scientific advances and a network of institutional relationships creates long-term value for stakeholders. To find out more about The Trout Group, contact Thomas Hoffmann, Managing Director, at thoffmann(at)troutgroup(dot)com or call 646-378-2931.

About the Conference Forum:
The Conference Forum is a research firm that develops specialized events for professionals in the life science and healthcare industries. The company currently offers conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange ideas and provide quality networking to help move therapeutics to patients faster.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14601086.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. CNA Finance Initiates Research Coverage On Next Group Holdings, Inc.
2. Atreo Group Presents Pneumatic Tube System Upgrade Options at American Society for Healthcare Engineering Conference
3. Trinity Sterile Selects The Copley Consulting Group to Implement Infor’s CloudSuite Industrial (Syteline)™ Solution
4. Endo Completes Divestiture of Litha Healthcare Group
5. XIO Group Announces Completion of the COMPO Expert State-of-the-Art Production Plant
6. AESKU.GROUP Acquires DST Diagnostische Systeme & Technologien GmbH
7. Boyd Technologies Selects The Copley Consulting Group to ImplementInfor’s CloudSuite Industrial (SyteLine)TM Solution
8. Leading Pharma and Research Organizations to Attend Genedata Screener Global User Group Meetings
9. The Worth Group Unveils First Health and Wellness Summit
10. Global ID Group Sponsors Complimentary Webinar Featuring a Better Way to Assess Supply Chain Risks
11. Superior Controls and Banks Integration Group Merge, Creating Industry-Leading Biotech System Integration Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):